Source - SMW
Britain's Serious Fraud Office said it had dropped investigations into individuals at GlaxoSmithKline and Rolls-Royce.

'After an extensive and careful examination I have concluded that there is either insufficient evidence to provide a realistic prospect of conviction or it is not in the public interest to bring a prosecution in these cases,' SFO director Lisa Osofsky said.

GlaxoSmithKline said it was pleased that the SFO had closed its investigation and that no further action was required.


At 1:08pm:

(LON:GSK) GlaxoSmithKline PLC share price was -7.2p at 1530.8p

(LON:RR.) RollsRoyce Group PLC share price was +5.5p at 987.1p